Trilogy International Partners Inc T.TRL.WT.A

RE:help please.

[PitchinPennies]

Hello, Clangordon and welcome to this board.

First off, you can't compare Pfizer with the box of broken toys called Acerus. Pfizer's sildenafil (Viagra) for erectile dysfunction was an efficacious drug, best in it's class, and was marketed by the best minds in pharma. The success of Viagra is the basis for many business school case studies. It was historically successful.

Acerus is competing in a different category, namely male hormone replacement therapy. This is a much more medically controversial area, and across the category is a difficult sell. The class is dominated by long-established, well-heeled Big Pharma companies that have established relationships with physicians and other stakeholders. It was never going to be an easy market to crack, but throughout the decade they've been trying to get traction on their lead product, Acerus demonstrated poor vision, bad planning, worse execution, aversion to accepting reality, along with a truly remarkable string of bad luck. You might say the root problem is hubris. They still don't know how much they don't know. There's also the unfortunate element of a pervasive "bunker mentality" stemming from the chairman's feud with the company's founder.

The share consolidation is only the most recent miscalculation. The stock is down another 40% from the date when the 200-to-one split was announced. As the AGM approachs, the trading volume of these $3.10 shares today was... exactly two shares. Your comment about the relentless quest to hit zero is exactly right. I wish I could offer some potential upside to all this, but there isn't one. The two or three posters who used to defend this company are off cowering in a doorway somewhere. It's nearly midnight at Acerus.